Copy of 5 24



CAR-T therapy for ALL 


Wednesday 星期三, 24-11-2021  |  17:00 - 18:00 ( UTC+8  | SGT )  

Check your Time Zone 



Screenshot 2021 10 25 101714



For parents, coping and caring for a child with acute lymphoblastic leukemia (ALL) can be challenging, including the choice of treatments such as chemotherapy, radiation therapy, surgery and bone marrow transplantation. Though these treatments are useful, they are not always successful and could result in many long-term side effects. Recently, chimeric antigen receptor modified T cells (CAR-T) become a new form of treatment for ALL. In this webinar, Dr. Chan,Dr Leung and Dr Li will share practical information with patients, survivors, their family members and caregivers on CAR-T Therapy and how it can save more children with ALL with less side effects.

应对和照顾患有急性淋巴细胞白血病(ALL)的孩子,对父母是一项艰巨的挑战,包括该选择化疗、放射治疗、手术还是骨髓移植等治疗方案?这些虽然是有效的治疗方案,但未必适用于每个病童,并且可能导致许多长期的副作用。嵌合抗原受体修饰T细胞(CAR-T)是近期治疗ALL的一种新方案。在本次网络研讨会上,梁医生,陈医生和李医生将与患者、康复者、他们的家人和护理人员分享有关CAR-T治疗的实用信息,以及它如何能够以较少的副作用挽救更多患有 ALL 的儿童。

If you can't make it, you can still register to receive a copy of the webinar recording.

Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA's Attendance Policy.



 Branding Webinar 18



Michelle Hermiston

Dr Wing Leung

Head of Department
Clinical Professor
Department of Paediatrics and Adolescent Medicine
LKS Faculty of Medicine
The University of Hong Kong

Professor Wing Leung, MBBS PhD, is a Senior Consultant in Hematology and Oncology at KK Women’s and Children’s Hospital and a Professor at Duke-NUS Medical School in Singapore. He is the Chair of the TCL-CCF Professorship and the Director of Pediatric Bone Marrow Transplant and Cellular Therapy Center. Previously, he was the Chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital and Vice President of Clinical Development at Miltenyi Biotec. Prof. Leung obtained his medical degree from the University of Hong Kong and a Ph.D. from the Johns Hopkins University. He is a diplomate certified in general pediatrics and in pediatric hematology-oncology by the American Board of Pediatrics. Prof. Leung has a major research interest in the biology of human natural killer cells and memory T cells, specifically the clinical applications in hematopoietic stem cell transplantation and cellular therapy. His research received continuous funding from the National Institutes of Health. He is an elected Member of the American Society for Clinical Investigation.

TC Quah

Dr Godfrey Chan

Clinical Professor
Tsao Yen-Chow Endowed Professor in Paediatrics and Adolescent Medicine
Department of Paediatrics and Adolescent Medicine
LKS Faculty of Medicine, The University of Hong Kong

Chief of Service
Department of Paediatrics and Adolescent Medicine,
Hong Kong Children's Hospital / HKU-Shenzhen Hospital / Gleneagles Hospital


Prof. Chan graduated from Dentistry (DMD, Cum Laude & Valedictorian 1981) and Medicine (MD, 1985) respectively from University of the East, Philippines and is currently both a registered dentist and medical doctor in Hong Kong. He joined the Department of Pediatrics of the University of Hong Kong in 1989. Then he pursued further training at the St. Jude Children’s Research Hospital, USA as a fellow from 1993 to 1996. He then obtained Dip of Palliative Medicine (1997) from University of Wales and MSc from University of Birmingham (1999). He joined the Faculty of Medicine, University of Hong Kong as Clinical Associate Professor in 1999, and was appointed as the Assistant Dean (External Affair) of the LKS Faculty of Medicine from 2004 to 2013. He was promoted to Clinical Professor in 2009. Since 2012, he has been the Head & Chief of Service of the Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital & HKU-Shenzhen Hospital, The University of Hong Kong. He was awarded Tsao Yen-Chow Endowed Professorship of Pediatrics & Adolescent Medicine in 2013. He is currently the Director of the Molecular Laboratory for Traditional Chinese Medicine, HKU. He has recently been appointed as the Chief of Service and Service Head of Pediatric Oncology for The Hong Kong Children’s Hospital since Oct 2018. He supervised >50 MSc & PhD students and published >300 full articles, 10 book chapters and 1 book. He serves as editor for 12 journals and is the immediate past Chief Editor of Hong Kong Journal of Paediatrics. He received multiple prestigious research grants with a total amount over US$ 6millions. He owned 5 patents including 3 on collagen microsphere device for the delivery of human mesenchymal stem cells. He has multiple International Awards (ANR, SIOP, ASPR, Endeavor Executive Award-Australian Government, Outstanding Pediatrician of APPA) for his clinical and laboratory research works on childhood neurogenic tumors and stem cells biology. His research interest includes the immunological aspects of stem cells, cancers and thalassemia. He is the Immediate Past Chairman of St Jude-VIVA-Asia Pediatric BMT Consortium, Regional Chairman (Asia, Australia & Africa) of Advance in Neuroblastoma Research, Secretary of the Asian Pediatric Hematology Oncology Group, and was the President of Hong Kong Pediatric Society.


Michelle Hermiston

Dr Benshang Li

Chief physician of the Department of Hematology&Oncology and Director of Clinical Hematology Oncology Laboratory

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine


Deputy Director, Department of Hematology and Oncology, Shanghai Children's Medical Center,Director of Clinical Hematology Oncology Laboratory,National Health Commission Key Laboratory of Children's Hematology Tumor PI.Currently a clinical genetics of the Chinese Medical Doctor Association,Member of the Immunology Group,Member of the Precision Medicine Professional Committee of the Pediatrics Branch of the Chinese Medical Association.Good at the detection and monitoring of minimal residual disease of childhood hematological tumor diseases,Molecular diagnosis of difficult and rare hematological diseases and CAR-T cell therapy for hematological tumor diseases.Has participated in and presided over a number of National Natural Science Foundations,Scientific Research Fund of Shanghai Science and Technology Commission,Scientific Research Fund of Shanghai Municipal Health Bureau,Research Fund of Shanghai Jiaotong University,Research work on topics such as the China Postdoctoral Research Fund.Mainly engaged in leukemia genomics research and CAR-T treatment technology research. 


Pre webinar video 11